Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of €6.50 billion as of August 14, 2025. Its market cap has decreased by -0.32% in one year.

Market Cap

6.50B

Enterprise Value

7.35B

Revenue

1.00B

Ranking

n/a

PE Ratio

13.70

Stock Price

€49.94

Market Cap Chart

Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 141.66M to 6.50B, an increase of 4,490.53%. That is a compound annual growth rate of 19.72%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	6.50B	10.68%
Dec 31, 2024	5.88B	33.01%
Dec 29, 2023	4.42B	-38.64%
Dec 30, 2022	7.20B	44.69%
Dec 31, 2021	4.98B	5.58%
Dec 31, 2020	4.71B	104.10%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
UniCredit	104.91B
Intesa Sanpaolo	94.67B
Enel SpA	79.33B
Ferrari	67.79B
Assicurazioni Generali	50.84B
Eni S.p.A.	44.81B
Leonardo S.p.a.	26.00B
Poste Italiane	25.45B

Market Cap Rankings